1. Home
  2. ABOS vs SRBK Comparison

ABOS vs SRBK Comparison

Compare ABOS & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • SRBK
  • Stock Information
  • Founded
  • ABOS 1996
  • SRBK 1887
  • Country
  • ABOS United States
  • SRBK United States
  • Employees
  • ABOS N/A
  • SRBK N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • SRBK
  • Sector
  • ABOS Health Care
  • SRBK
  • Exchange
  • ABOS Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • ABOS 99.1M
  • SRBK 104.5M
  • IPO Year
  • ABOS 2021
  • SRBK N/A
  • Fundamental
  • Price
  • ABOS $1.65
  • SRBK $11.99
  • Analyst Decision
  • ABOS Strong Buy
  • SRBK
  • Analyst Count
  • ABOS 3
  • SRBK 0
  • Target Price
  • ABOS $9.33
  • SRBK N/A
  • AVG Volume (30 Days)
  • ABOS 412.7K
  • SRBK 18.8K
  • Earning Date
  • ABOS 11-12-2024
  • SRBK 01-01-0001
  • Dividend Yield
  • ABOS N/A
  • SRBK N/A
  • EPS Growth
  • ABOS N/A
  • SRBK N/A
  • EPS
  • ABOS N/A
  • SRBK 0.11
  • Revenue
  • ABOS N/A
  • SRBK $30,867,000.00
  • Revenue This Year
  • ABOS N/A
  • SRBK N/A
  • Revenue Next Year
  • ABOS N/A
  • SRBK N/A
  • P/E Ratio
  • ABOS N/A
  • SRBK $105.06
  • Revenue Growth
  • ABOS N/A
  • SRBK 164.18
  • 52 Week Low
  • ABOS $1.53
  • SRBK $8.94
  • 52 Week High
  • ABOS $5.09
  • SRBK $12.76
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 39.18
  • SRBK 56.32
  • Support Level
  • ABOS $1.54
  • SRBK $11.78
  • Resistance Level
  • ABOS $1.75
  • SRBK $11.95
  • Average True Range (ATR)
  • ABOS 0.13
  • SRBK 0.18
  • MACD
  • ABOS 0.01
  • SRBK -0.03
  • Stochastic Oscillator
  • ABOS 28.57
  • SRBK 41.92

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: